Nanogen, Spectral Diagnostics deal

NGEN completed its previously announced acquisition of SDI's rapid cardiac immunoassay test business for C$5.7 million (US$ 4.9 million) in cash and C$3.4 million (US$ 2.9 million) in NGEN stock (see ...